Cambridge Investment Research Advisors’s iShares Core MSCI Total International Stock ETF IXUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86.3M Buy
903,872
+9,191
+1% +$864K 0.19% 92
2026
Q1
$77.5M Buy
894,681
+132,925
+17% +$11.8M 0.2% 97
2025
Q4
$64.5M Buy
761,756
+54,923
+8% +$4.6M 0.17% 107
2025
Q3
$58.4M Sell
706,833
-104,990
-13% -$8.35M 0.16% 112
2025
Q2
$62.8M Buy
811,823
+68,431
+9% +$5M 0.19% 96
2025
Q1
$51.9M Sell
743,392
-2,536
-0.3% -$176K 0.18% 110
2024
Q4
$49.3M Buy
745,928
+13,339
+2% +$926K 0.16% 110
2024
Q3
$53.2M Sell
732,589
-10,000
-1% -$693K 0.18% 99
2024
Q2
$50.2M Buy
742,589
+3,996
+0.5% +$271K 0.19% 100
2024
Q1
$50.1M Buy
738,593
+88,125
+14% +$5.75M 0.19% 92
2023
Q4
$42.2M Sell
650,468
-34,766
-5% -$2.13M 0.18% 98
2023
Q3
$41.1M Buy
685,234
+11,494
+2% +$717K 0.19% 97
2023
Q2
$42.2M Buy
673,740
+9,897
+1% +$620K 0.19% 99
2023
Q1
$41.1M Sell
663,843
-3,691
-0.6% -$226K 0.2% 96
2022
Q4
$38.6M Buy
667,534
+44,249
+7% +$2.47M 0.2% 97
2022
Q3
$31.7M Buy
623,285
+3,450
+0.6% +$196K 0.18% 103
2022
Q2
$35.3M Buy
619,835
+61,255
+11% +$3.77M 0.19% 102
2022
Q1
$37.2M Buy
558,580
+27,511
+5% +$1.87M 0.17% 108
2021
Q4
$37.7M Buy
531,069
+38,497
+8% +$2.77M 0.17% 115
2021
Q3
$35M Buy
492,572
+47,819
+11% +$3.49M 0.17% 112
2021
Q2
$32.6M Buy
444,753
+19,870
+5% +$1.45M 0.16% 126
2021
Q1
$29.9M Buy
424,883
+34,432
+9% +$2.41M 0.16% 129
2020
Q4
$26.2M Buy
390,451
+23,852
+7% +$1.5M 0.15% 131
2020
Q3
$21.4M Buy
366,599
+44,055
+14% +$2.57M 0.14% 152
2020
Q2
$17.6M Buy
322,544
+159,102
+97% +$8.18M 0.13% 163
2020
Q1
$7.68M Buy
163,442
+13,269
+9% +$750K 0.07% 258
2019
Q4
$9.3M Buy
150,173
+56,830
+61% +$3.41M 0.07% 263
2019
Q3
$5.39M Buy
93,343
+6,105
+7% +$350K 0.05% 379
2019
Q2
$5.12M Sell
87,238
-21,946
-20% -$1.28M 0.05% 380
2019
Q1
$6.34M Sell
109,184
-82,819
-43% -$4.68M 0.06% 293
2018
Q4
$10.1M Buy
192,003
+19,935
+12% +$1.11M 0.11% 182
2018
Q3
$10.4M Buy
172,068
+36,837
+27% +$2.22M 0.1% 199
2018
Q2
$8.13M Buy
135,231
+19,464
+17% +$1.22M 0.09% 227
2018
Q1
$7.3M Sell
115,767
-22,410
-16% -$1.44M 0.08% 241
2017
Q4
$8.72M Buy
138,177
+15,473
+13% +$962K 0.1% 192
2017
Q3
$7.48M Sell
122,704
-12,677
-9% -$754K 0.1% 193
2017
Q2
$7.76M Buy
135,381
+72,844
+116% +$4.14M 0.11% 157
2017
Q1
$3.42M Buy
62,537
+18,332
+41% +$977K 0.06% 308
2016
Q4
$2.23M Buy
44,205
+14,620
+49% +$743K 0.04% 408
2016
Q3
$1.54M Buy
29,585
+3,658
+14% +$187K 0.03% 505
2016
Q2
$1.27M Buy
25,927
+1,781
+7% +$88.5K 0.03% 508
2016
Q1
$1.19M Buy
24,146
+4,833
+25% +$226K 0.03% 502
2015
Q4
$956K Buy
19,313
+8,344
+76% +$426K 0.02% 561
2015
Q3
$536K Sell
10,969
-2,701
-20% -$141K 0.02% 732
2015
Q2
$753K Buy
13,670
+3,692
+37% +$213K 0.02% 621
2015
Q1
$553K Buy
+9,978
New +$544K 0.02% 745

Other funds holding IXUS

Cambridge Investment Research Advisors's IXUS Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its iShares Core MSCI Total International Stock ETF (IXUS) stake by 1% in Q2 2026, buying an estimated $864K and bringing the position to 903,872 shares worth $86.3M. The position accounts for 0.19% of the portfolio, ranked #92.

Cambridge Investment Research Advisors first reported a position in IXUS in Q1 2015 and has held it in 46 quarters since. 1,052 funds tracked by Wall St. Rank hold IXUS as of Q2 2026.

  • Cambridge Investment Research Advisors held 903,872 shares of iShares Core MSCI Total International Stock ETF worth $86.3M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 9,191 iShares Core MSCI Total International Stock ETF shares in Q2 2026, an estimated $864K.
  • iShares Core MSCI Total International Stock ETF made up 0.19% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #92 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares Core MSCI Total International Stock ETF in Q1 2015 and has held it in 46 quarters since.
  • 1,052 funds tracked by Wall St. Rank held iShares Core MSCI Total International Stock ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.